Introduction
The human inflammatory periodontal diseases are amongst the most common of chronic diseases to affect adults. In the UK, 69% of adults have early signs of disease and only 5% are completely free from clinical signs of inflammation.' The periodontal complex comprises alveolar bone, periodontal ligament, root cementum, and the overlying gingival (gum) tissues (fig 1) . Gingivitis may be defined as "an inflammatory lesion, mediated by hostparasite interactions, that is confined to the gingival tissues". The major cause of gingivitis is an accumulation of microbial plaque in and around the dento-gingival complex, which, when removed, results in complete resolution of the inflammatory lesion.2 Periodontitis is regarded as "an inflammatory lesion, mediated by complex host-parasite interactions, that leads to the loss of connective tissue attachment to root surface cementum and adjacent alveolar bone". There are many forms of periodontitis' and the changes associated with periodontitis are irreversible, resulting in tooth loss and substantial morbidity in medically compromised patients, where a focus of infection and subsequent bacteraemia may present a major risk.
The mouth possesses a unique hard/soft tissue barrier, that separates the internal systems from the external environment. The barrier (fig 1) is called the junctional epithelium and is permeable to external (bacterial) material passing into the adjacent connective tissues and blood stream, and to products of internal defence systems (leucocytes, complement, antibodies, pro-inflammatory cytokines, etc.) passing outwards. To assist this vulnerable barrier in protecting the underlying host tissues from damage by products of bacterial plaque, a fluid, gingival crevicular fluid (GCF), is produced from beneath the gingival margin. In health, GCF is a serum transudate containingall components of serum and also polymorphonuclear leucocyte cells, but during disease many products of the host-parasite conflict enter the fluid, which becomes a true exudate. GCF may be collected non-invasively on paper strips4 (fig 2) , providing an ideal medium in which to study the complex bacterial-host interactions (fig 3) that characterise other similar inflammatory disorders.
Substantial data are available in the literature on the role of reactive oxygen species (ROS) and antioxidants in disorders such as the inflammatory lung diseases and in chronic immune mediated conditions such as rheumatoid arthritis. However, remarkably little information is available on the periodontal diseases, which show many of the pathological features of other chronic inflammatory diseases. The periodontal tissues also provide an ideal medium within which to study mechanisms of ROS mediated tissue damage and of antioxidant defence in response to bacterial colonisation, through the non-invasive collection of GCF. This paper, therefore, attempts to review current knowledge of free radical damage and antioxidant defence systems in inflammatory diseases, and to use the inflammatory periodontal diseases as a focus for discussion. Emphasis is placed upon the presence of low molecular weight thiols such as reduced glutathione (GSH) and cysteine in fluids that bathe vulnerable epithelial surfaces, and it is postulated that new therapeutic pathways may be found by using cysteine and GSH preserving drugs-for example, N-acetylcysteine, or indeed, inhibitors of the nuclear transcription factor NF-KB.
Inflammatory cells and reactive oxygen species There is good evidence arising from studies of defective neutrophil function in ChediakHigashi syndrome,5 acatalasia,6 Job's syndrome,5 and chronic granulomatous disease,7 where profound tissue inflammation can lead to periodontal destruction, that the polymorphonuclear leucocyte has a protective role in the periodontal environment. However, evidence is emerging from several studies'-'0 that in early onset forms of periodontitis, polymorphonuclear leucocytes are functionally activated and exhibit increased free radical production as measured by luminol dependent chemiluminescence. Indeed, peripheral blood monocytes from patients with periodontitis demonstrate higher prostaglandin E2 production upon stimulation than those from patients of prostaglandin F2-like compounds,32 33 a prostanoid involved in lymphokine production, vasodilation, and osteoclastic resorption of bone. Lipid peroxidation end products also cause a dysfunction of Ca2+-ATPase34 and may cause opening of intracellular pores,34 both of which lead to an accumulation of intracellular calcium. The Ca2' build up causes activation of Ca2' dependent enzymes (proteases and phospholipase), which in turn cause cell damage. In addition, protein damage can arise via radical mediated inactivation of membrane bound receptors and enzymes36 and damage to glycoproteins. 37 Other mechanisms of hydroxyl mediated tissue damage involve DNA strand breaks38 and base hydroxylations,39 40 Mechanisms of preventing hydroxyl radical induced tissue damage include the binding of transition metal ions by the "preventative antioxidants" albumin, caeruloplasmin, haptoglobin, lactoferrin, and transferrin. Scavengers of the hydroxyl radical include vitamin C, uric acid42 and thiols, such as reduced glutathione20 and cysteine.
HYDROGEN PEROXIDE
Hydrogen peroxide can be produced by periodontal bacteria, by phagocytes from the NADPH oxidase shunt and also after dismutation of superoxide. While only a weak oxidant, it is has high potential to produce damage due to its ability to diffuse freely across cell membranes43 and undergo Fenton reactions with transition metals, thereby giving rise to site directed or site specific generation of 'OH.44 It has been proposed that hydrogen peroxide may act as a metabolic signal by oxidising protein thiol groups and triggering intracellular events. 43 An example would be the oxidation of an important nuclear regulatory protein NFKB, a process thought to be responsible for the expression of HIV genes. 45 The activity of hydrogen peroxide on NF-KB is also responsible for the transcription of several pro-inflammatory cytokines46 of importance to periodontal disease pathogenesis, including interleukin-2 (IL-2), IL-6, IL-8, 1-interferon, and tumour necrosis factor ct (TNFax).4 NF-KB activation ( fig 5) can also be caused by bacterial endotoxins, IL-1 and TNFa.48-51 The process is rapid, as NF-KB exists in the cytoplasm of most inflammatory cells, in a complex with an inhibited form (I-KB). Cytokines such as TNF-oc and IL-I are able to activate NF-KB via protein kinase C and other kinases, which phosphorylate the I-KB part of the cytoplasmic complex, thereby releasing free NF-KB rapidly and without the need for lengthy protein synthesis. The free NF-KB diffuses from the cytoplasm, across the nuclear membrane and binds to DNA, stimulating the transcription of mRNA for the various proinflammatory cytokines. Recently, it has been shown that bacterial lipopolysaccharide (LPS/endotoxin) can also activate macrophage NF-KB and subsequent cytokine transcription in a protein kinase C independent manner.5' As IL-1 and TNFoc positively regulate their own production through the NF-KB system, it is possible that the additive effects of endotoxin mediated cytokine production and that arising from the respiratory burst of polymorphonuclear leucocytes in response to the same organisms, could lead to substantial periodontal inflammation and subsequent It is unlikely that individual vitamin deficiencies have significant detrimental effects on the periodontium, but the combined effects of vitamins A, C and E have potential as therapeutic adjuncts in view of their powerful antioxidant activities.
ASCORBIC ACID (VITAMIN C)
Ascorbate protects against oxidants present in cigarette smoke4' and is a powerful scavenger of hypochlorous acid, superoxide, singlet oxygen, and hydroxyl radicals. It also possesses the ability to regenerate a-tocopherol from the tocopherol radical that forms at membrane surfaces. GCF concentrations of ascorbic acid have been reported to be three times higher than those of plasma59 and it has been shown to prevent activation of neutrophil derived collagenase55 in GCF. In rheumatoid arthritis60 plasma ascorbate concentrations are low but there is little evidence for any relation between plasma ascorbate concentrations and inflammatory periodontitis,6' though increased gingival bleeding is a common result of ascorbate depletion.6'""
Alpha-tocopherol is located within cell membrane phospholipids and is a major chain breaking antioxidant64 but has limited mobility, which restricts its efficacy.65 However, many reactive oxygen species are generated in aqueous solution, particularly those from phagocytes and the vascular endothelium, and the role of x-tocopherol in the pathogenesis of the periodontal diseases is thus likely to be a minor one. In one study66 no differences were detected in plasma vitamin E concentrations in patients with and without periodontal disease, and in another,67 its prostaglandin inhibitory properties were credited for reducing periodontal inflammation.
URIC ACID Uric acid is a relatively powerful scavenging antioxidant of water soluble radicals,68 such as hypochlorous acid and singlet oxygen. It can also bind copper and iron ions and increased concentrations of uric acid breakdown products are reported in patients with rheumatoid arthritis.69 Reaction of uric acid with some radicals (for example, OH) can produce uric acid radicals, but these are easily removed by ascorbate. 70 It has recently been reported that uric acid is the major (>70%) antioxidant in saliva56 and while it is also found in GCF, its antioxidant contribution to GCF has not been investigated.
CYSTEINE AND REDUCED GLUTATHIONE
Glutathione is an essential tripeptide with many important functions. In its reduced form (GSH) glutathione is an important antioxidant (radical scavenger), a property bestowed upon it by its central thiol containing cysteine amino acid. It is also regarded as a pivotal molecule to the immune system,7' especially for regulation of IL-2 dependent T-lymphocyte prolif- [72] [73] [74] eration.
The role of reduced glutathione (GSH) in the regulation of pro-inflammatory cytokines75 is of great potential importance in periodontal disease. There is evidence that increasing cytosolic cysteine (and thus GSH) concentrations of monocytes and macrophages (using a synthetic form of cysteine called N-acetylcysteine) blocks Certain putative periodontopathogens are capable of metabolising L-cysteine or degrading GSH to form hydrogen sulphide within the periodontal pocket.83-86 The formation of hydrogen sulphide within the periodontal pocket is toxic to mammalian cells by inactivating cytochrome oxidase87 and is also reported to inhibit catalase.88 It can be seen how the degradation of cysteine by oral microbiota may also prevent the inhibition of NF-KB mediated production of pro-inflammatory cytokines in the periodontal environment, thereby increasing the risk of cytokine related tissue damage.
THE CONCEPT OF TOTAL ANTIOXIDANT CAPACITY As ROS and antioxidant defence mechanisms seem to act in concert rather than alone, an example being the re-cycling of a-tocopherol by vitamin C, studies of individual antioxidants in relation to inflammatory disease may not necessarily yield useful information. Research is now being directed towards assays for total antioxidant capacities of biological fluids, while not forgetting the importance of the constituent antioxidant compounds. Wayner et al89 have reported the measurement of total peroxyl radical trapping parameter (TRAP assay), which is sensitive to all known chain breaking antioxidants but is a complex and time consuming assay to perform. Our group has recently reported a rapid and simple enhanced chemiluminescence (ECL) assay57 90 for total antioxidant quantification in biological fluids including serum, saliva and GCF. Initial data have revealed a reduced salivary total antioxidant concentration in patients with periodontitis relative to those with periodontal health, with no differences in serum concentrations. Guarnieri et al9' investigated GCF superoxide scavenging capacity in 14 patients with adult periodontitis and 16 healthy controls. They found no difference between test and control groups. The differences in results may be explained by the fact that in this study GCF was collected by a crevice washing tech 
